NTRK2 and Alzheimer disease: The use of BDNF mimetics and TrkB agonists such as 7,8-dihydroxyflavone (7,8-DHF) and ENT-A011 are also being explored in studies targeting the BDNF/TrkB signalling pathway as a therapeutic approach for AD [130,131].